{"id":1548,"date":"2016-06-10T09:44:00","date_gmt":"2016-06-10T14:44:00","guid":{"rendered":"https:\/\/www.rqmplus.com\/?p=1548"},"modified":"2025-09-03T09:39:12","modified_gmt":"2025-09-03T14:39:12","slug":"the-de-novo-pathway-is-it-right-for-my-device","status":"publish","type":"post","link":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/","title":{"rendered":"The de novo Pathway: Is It Right for My Device?"},"content":{"rendered":"\n<p><em>In December 2021, RQM+ acquired AcKnowledge Regulatory Strategies (AcKnowledge RS), a San Diego-based firm specializing in regulatory affairs consulting for the medical device and IVD industry. The integration of this impressive team enhances the extensive RQM+ network of current and former FDA reviewers, scientists, engineers and regulatory and quality experts, and adds additional expertise with FDA submissions. The author of this post is a member of this team, which has done significant work with novel and\/or high-risk devices focusing on pre-submissions, 510(k)s, IDEs, PMAs, De Novos, Breakthrough Designation Requests and Safer Technology Program Requests.&nbsp;<\/em><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>&#8220;Should I pursue a <em>de novo<\/em>&nbsp;classification for my medical device?&#8221; &#8220;Is the <em>de novo<\/em> pathway the right regulatory pathway for my medical device submission?&#8221;<\/p>\n\n\n\n<p>If you&#8217;re asking these questions, you&#8217;re not alone. Unsurprisingly, the most common answer I give clients who ask me these question is, \u201cIt depends.&#8221; That answer also happens to be one of the top most annoying responses to hear from a regulatory consultant. So, I typically like to follow it up with, &#8220;Tell me more about your device, your competitors, and the current standard of care, and let&#8217;s figure out if the <em>de novo<\/em> pathway is right for you!&#8221;<\/p>\n\n\n\n<p>The best way to approach this decision is probably to understand how and why the <em>de novo<\/em> classification came to be.&nbsp;Prior to the 1997 Food and Drug Administration Modernization Act (FDAMA), the <em>de novo<\/em> pathway didn&#8217;t exist. Until then, devices that received an NSE (not substantially equivalent) determination in response to a premarket notification [510(k)] submission were automatically deemed Class III. Class III devices are those considered high risk, therefore requiring the often lengthier Premarket Approval (PMA) process: this new <em>de novo<\/em> process was designed to usher through any new device that was both 1) unprecedented (novel),&nbsp;and 2) low to moderate risk (or with risk that was easily mitigated). It excluded devices that had already been put into Class III, but it offered a four step automatic reclassification process for novel devices using a risk-based strategy.<\/p>\n\n\n\n<p>The 4-step process consists of: (1) the sponsor submitting a premarket notification [510(k)], (2) FDA making a Not Substantially Equivalent (NSE) decision due to lack of predicate, (3) the sponsor submitting a <em>de novo<\/em> application, and (4) FDA reviewing the application and making a final decision to approve or deny it.<\/p>\n\n\n\n<p>This process was streamlined in 2012 when FDA further modified the FD&amp;C Act under the Food and Drug Administration Safety and Innovation Act (FDASIA)&nbsp;to, in <a target=\"_blank\" href=\"http:\/\/www.fda.gov\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDRH\/CDRHTransparency\/ucm232269.htm\" rel=\"noreferrer noopener\">their words<\/a>, &#8220;allow a sponsor to submit a <em>de novo<\/em> classification request to the FDA for novel low to moderate risk devices without first being required to submit a 510(k).&#8221;&nbsp;They added a more efficient, two-step, automatic reclassification process consisting of just the last two steps of the four-step process outlined above. This allows the sponsor to skip the 510(k) and NSE decision. However, the <em>de novo<\/em>&nbsp;application in both processes should either refer to a previous 510(k) or include all the relevant information recommended for a 510(k) submission. Also keep in mind that the <em>de novo<\/em>&nbsp;application should sufficiently address the characterization of all health risks of the device, as well as how those risks might be mitigated.&nbsp;FDA will then review the application, and may work with the sponsor to get more information. If FDA grants the decision,&nbsp;the device can be legally marketed and the new classification (and any applicable special controls) will be published in the Federal Register Notice.<\/p>\n\n\n\n<p>In short, if you have a novel technology that isn\u2019t considered high risk (or if the risks can be adequately mitigated) you might be able to get on the market without a costly, lengthy PMA. A <em>de novo<\/em>&nbsp;classification for your device may then pave the way for other companies to use your device as a predicate:&nbsp;you will have helped decide the regulatory requirements for future clearances, and have the \u201cfirst-to-market\u201d claim with your technology.&nbsp;<\/p>\n\n\n\n<p>One more thing to keep in mind: FDA strongly encourages a Pre-Submission (Pre-Sub) to informally request guidance on a novel device. However, a sponsor should only submit a Pre-Sub for a <em>de novo<\/em> application after the device design and intended use are established. It&#8217;s also recommended that the sponsor have adequate information collected regarding the safety and effectiveness of the device.<\/p>\n\n\n\n<p>If you can submit an acceptable <em>de novo<\/em> application where the necessary performance testing is completed, the risks to health have been mitigated, and the special controls have been identified, then FDA aims to have a decision to you within 60 days.&nbsp;When deciding whether the <em>de novo<\/em> pathway is right for your company, be sure to do your homework and regulatory research to show that your device is <em>de novo<\/em> eligible.<\/p>\n\n\n\n<p>It&#8217;s never been easier to do so, as in recent years the number of successful submissions has increased, and information about them has become more accessible:<\/p>\n\n\n\n<p>For starters,&nbsp;make sure that your device is in fact new, and not already classified, by researching the available FDA databases (<a target=\"_blank\" href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm\" rel=\"noreferrer noopener\">510(k)<\/a>, <a target=\"_blank\" href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm\" rel=\"noreferrer noopener\">PMA<\/a>,&nbsp;<a target=\"_blank\" href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpcd\/classification.cfm\" rel=\"noreferrer noopener\">Product Classification<\/a>) and prior <a target=\"_blank\" href=\"http:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/DeviceApprovalsandClearances\/\" rel=\"noreferrer noopener\">FDA decisions<\/a>.<\/p>\n\n\n\n<p>Second, check out the FDA <em>de novo<\/em> classification process guidance document and read the <a target=\"_blank\" href=\"http:\/\/www.fda.gov\/downloads\/medicaldevices\/deviceregulationandguidance\/guidancedocuments\/ucm517504.pdf\" rel=\"noreferrer noopener\">FDA guidance on determining benefit-risk factors<\/a>.&nbsp;<\/p>\n\n\n\n<p>Additionally,&nbsp;in 2010 FDA began releasing summary documents for devices classified through the <em>de novo<\/em> process. The table shown below is featured on <a target=\"_blank\" href=\"http:\/\/www.fda.gov\/aboutfda\/centersoffices\/officeofmedicalproductsandtobacco\/cdrh\/cdrhtransparency\/ucm232269.htm\" rel=\"noreferrer noopener\">FDA&#8217;s Evaluation of Automatic Class III Designation (<em>de novo<\/em>) Summaries<\/a>, where you can read up on devices that have made it through this way.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.fda.gov\/about-fda\/cdrh-transparency\/evaluation-automatic-class-iii-designation-de-novo-summaries\" rel=\"noreferrer noopener\" target=\"_blank\">CLICK ON IMAGE TO SEE FULL TABLE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In December 2021, RQM+ acquired AcKnowledge Regulatory Strategies (AcKnowledge RS), a San Diego-based firm specializing in regulatory affairs consulting for&#8230;<\/p>\n","protected":false},"author":13,"featured_media":1753,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"resource-type":[28],"topic":[],"region":[],"class_list":["post-1548","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","resource-type-blog"],"acf":[],"card_info":{"title":"The de novo Pathway: Is It Right for My Device?","link":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/","link_target":"_self","name":"Blog","slug":"blog","thumbnail":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp","excerpt":"In December 2021, RQM+ acquired AcKnowledge Regulatory Strategies (AcKnowledge RS), a San Diego-based firm specializing in regulatory affairs consulting for...","display_date":"June 10, 2016"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The de novo Pathway: Is It Right for My Device? | RQM+<\/title>\n<meta name=\"description\" content=\"Should I pursue a de novo classification for my medical device? Is the de novo pathway the right regulatory pathway for my medical device submission?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The de novo Pathway: Is It Right for My Device? | RQM+\" \/>\n<meta property=\"og:description\" content=\"Should I pursue a de novo classification for my medical device? Is the de novo pathway the right regulatory pathway for my medical device submission?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/\" \/>\n<meta property=\"og:site_name\" content=\"RQM+\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RQMplus\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-10T14:44:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-03T14:39:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"765\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Alex Smith\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RQMplus\" \/>\n<meta name=\"twitter:site\" content=\"@RQMplus\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alex Smith\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/\"},\"author\":{\"name\":\"Alex Smith\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/person\/3a014f17a9e33ae269967ec748fea72e\"},\"headline\":\"The de novo Pathway: Is It Right for My Device?\",\"datePublished\":\"2016-06-10T14:44:00+00:00\",\"dateModified\":\"2025-09-03T14:39:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/\"},\"wordCount\":943,\"publisher\":{\"@id\":\"https:\/\/www.rqmplus.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/\",\"url\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/\",\"name\":\"The de novo Pathway: Is It Right for My Device? | RQM+\",\"isPartOf\":{\"@id\":\"https:\/\/www.rqmplus.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp\",\"datePublished\":\"2016-06-10T14:44:00+00:00\",\"dateModified\":\"2025-09-03T14:39:12+00:00\",\"description\":\"Should I pursue a de novo classification for my medical device? Is the de novo pathway the right regulatory pathway for my medical device submission?\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp\",\"width\":765,\"height\":500},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rqmplus.com\/#website\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"name\":\"RQM+\",\"description\":\"Evolving MedTech\",\"publisher\":{\"@id\":\"https:\/\/www.rqmplus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rqmplus.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rqmplus.com\/#organization\",\"name\":\"RQM+\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"width\":696,\"height\":696,\"caption\":\"RQM+\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/RQMplus\",\"https:\/\/x.com\/RQMplus\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/person\/3a014f17a9e33ae269967ec748fea72e\",\"name\":\"Alex Smith\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3be8dbfc1c464387bd9d6738f0b36f27bf821e4dbd6c61d63d9a28989361aed6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3be8dbfc1c464387bd9d6738f0b36f27bf821e4dbd6c61d63d9a28989361aed6?s=96&d=mm&r=g\",\"caption\":\"Alex Smith\"},\"url\":\"https:\/\/www.rqmplus.com\/blog\/author\/seoazonetwork-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The de novo Pathway: Is It Right for My Device? | RQM+","description":"Should I pursue a de novo classification for my medical device? Is the de novo pathway the right regulatory pathway for my medical device submission?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/","og_locale":"en_US","og_type":"article","og_title":"The de novo Pathway: Is It Right for My Device? | RQM+","og_description":"Should I pursue a de novo classification for my medical device? Is the de novo pathway the right regulatory pathway for my medical device submission?","og_url":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/","og_site_name":"RQM+","article_publisher":"https:\/\/www.facebook.com\/RQMplus","article_published_time":"2016-06-10T14:44:00+00:00","article_modified_time":"2025-09-03T14:39:12+00:00","og_image":[{"width":765,"height":500,"url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp","type":"image\/png"}],"author":"Alex Smith","twitter_card":"summary_large_image","twitter_creator":"@RQMplus","twitter_site":"@RQMplus","twitter_misc":{"Written by":"Alex Smith","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#article","isPartOf":{"@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/"},"author":{"name":"Alex Smith","@id":"https:\/\/www.rqmplus.com\/#\/schema\/person\/3a014f17a9e33ae269967ec748fea72e"},"headline":"The de novo Pathway: Is It Right for My Device?","datePublished":"2016-06-10T14:44:00+00:00","dateModified":"2025-09-03T14:39:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/"},"wordCount":943,"publisher":{"@id":"https:\/\/www.rqmplus.com\/#organization"},"image":{"@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/","url":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/","name":"The de novo Pathway: Is It Right for My Device? | RQM+","isPartOf":{"@id":"https:\/\/www.rqmplus.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage"},"image":{"@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp","datePublished":"2016-06-10T14:44:00+00:00","dateModified":"2025-09-03T14:39:12+00:00","description":"Should I pursue a de novo classification for my medical device? Is the de novo pathway the right regulatory pathway for my medical device submission?","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/blog\/the-de-novo-pathway-is-it-right-for-my-device\/#primaryimage","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/07\/Batteries-regulation-EU-20231542-AI-regulation-AI-Act-EU-20241689-Packagingpackaging-waste-regulation-EU-202540-European-Health-Data-Space-regulation-EU-2025327-1.webp","width":765,"height":500},{"@type":"WebSite","@id":"https:\/\/www.rqmplus.com\/#website","url":"https:\/\/www.rqmplus.com\/","name":"RQM+","description":"Evolving MedTech","publisher":{"@id":"https:\/\/www.rqmplus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rqmplus.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rqmplus.com\/#organization","name":"RQM+","url":"https:\/\/www.rqmplus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","width":696,"height":696,"caption":"RQM+"},"image":{"@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RQMplus","https:\/\/x.com\/RQMplus"]},{"@type":"Person","@id":"https:\/\/www.rqmplus.com\/#\/schema\/person\/3a014f17a9e33ae269967ec748fea72e","name":"Alex Smith","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3be8dbfc1c464387bd9d6738f0b36f27bf821e4dbd6c61d63d9a28989361aed6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3be8dbfc1c464387bd9d6738f0b36f27bf821e4dbd6c61d63d9a28989361aed6?s=96&d=mm&r=g","caption":"Alex Smith"},"url":"https:\/\/www.rqmplus.com\/blog\/author\/seoazonetwork-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/posts\/1548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/comments?post=1548"}],"version-history":[{"count":0,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/posts\/1548\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media\/1753"}],"wp:attachment":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media?parent=1548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/categories?post=1548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/tags?post=1548"},{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/resource-type?post=1548"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/topic?post=1548"},{"taxonomy":"region","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/region?post=1548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}